Pomelo Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Pomelo Capital’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,366,585	Closed	-$683K	–	83
2018 Q2	$683K	Sell	1,366,585 -143,415	-9%	-$66.8K	0.07%	65
2018 Q1	$638K	Hold	1,510,000	–	–	0.03%	95
2017 Q4	$574K	Hold	1,510,000	–	–	0.02%	131
2017 Q3	$544K	Hold	1,510,000	–	–	0.02%	126
2017 Q2	$574K	Buy	1,510,000 +110,000	+8%	+$44.9K	0.03%	108
2017 Q1	$630K	Hold	1,400,000	–	–	0.03%	113
2016 Q4	$532K	Hold	1,400,000	–	–	0.02%	137
2016 Q3	$378K	Hold	1,400,000	–	–	0.02%	145
2016 Q2	$336K	Hold	1,400,000	–	–	0.02%	138
2016 Q1	$160K	Hold	1,400,000	–	–	0.01%	138
2015 Q4	$158K	Buy	1,400,000 +176,946	+14%	+$25K	0.06%	91
2015 Q3	$233K	Buy	+1,223,054	New	+$416K	0.1%	83
2015 Q2	–	Hold	0	–	–	–	40
2015 Q1	–	Sell	-799,076	Closed	-$559K	–	39
2014 Q4	$631K	Sell	799,076 -250,000	-24%	-$171K	0.36%	36
2014 Q3	$488K	Hold	1,049,076	–	–	0.27%	28
2014 Q2	$525K	Hold	1,049,076	–	–	0.24%	31
2014 Q1	$325K	Buy	1,049,076 +450,000	+75%	+$167K	0.16%	34
2013 Q4	$204K	Buy	+599,076	New	+$724K	0.09%	43

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $1.26B AUM 194.27% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Pomelo Capital's GCVRZ Position: Q3 2018 in Review

Pomelo Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2018, closing a stake of 1,366,585 shares — an estimated $683K sold.

Pomelo Capital first reported a position in GCVRZ in Q4 2013 and held it in 17 quarters. The position peaked at $683K in Q2 2018. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2018.

Pomelo Capital reported no remaining Sanofi Contingent Value Rights position as of Q3 2018 after selling out during the quarter.
Pomelo Capital sold 1,366,585 Sanofi Contingent Value Rights shares in Q3 2018, an estimated $683K.
Pomelo Capital first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 17 quarters.
Pomelo Capital's Sanofi Contingent Value Rights position peaked at $683K in Q2 2018.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2018.

Based on Pomelo Capital's 13F filing for Q3 2018, filed 14 Nov 2018.